{"name": "Foundation Medicine",
 "permalink": "foundation-medicine",
 "crunchbase_url": "http://www.crunchbase.com/company/foundation-medicine",
 "homepage_url": "http://www.foundationmedicine.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "FoundationATCG",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2010,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "dna-sequencing, diagnostic-tests",
 "alias_list": "",
 "email_address": "info@foundationmedicine.com",
 "phone_number": "617-418-2200",
 "description": "Genetic sequencing lab tests",
 "created_at": "Mon Apr 19 15:52:26 UTC 2010",
 "updated_at": "Mon Mar 18 06:33:42 UTC 2013",
 "overview": "\u003Cp\u003EFoundation Medicine plans to create clinical diagnostic tests that can use the latest in genetic sequencing technology to identify personalized cancer therapies for patients.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       84],
      "assets/images/resized/0013/4432/134432v1-max-150x150.png"],
     [[214,
       120],
      "assets/images/resized/0013/4432/134432v1-max-250x250.png"],
     [[214,
       120],
      "assets/images/resized/0013/4432/134432v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Michael",
      "last_name": "J. Pellini",
      "permalink": "michael-j-pellini",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Brook",
      "last_name": "Byers",
      "permalink": "brook-byers",
      "image":
       {"available_sizes":
         [[[150,
            100],
           "assets/images/resized/0001/9594/19594v2-max-150x150.jpg"],
          [[250,
            166],
           "assets/images/resized/0001/9594/19594v2-max-250x250.jpg"],
          [[450,
            300],
           "assets/images/resized/0001/9594/19594v2-max-450x450.jpg"]],
        "attribution": "\u003Cp\u003E\u003Ca href=\"http://www.kpcb.com/team/index.php?Brook%20Byers\" title=\"KPCB\" rel=\"nofollow\"\u003EKPCB\u003C/a\u003E\u003C/p\u003E"}}},
   {"is_past": true,
    "title": "CFO",
    "person":
     {"first_name": "David",
      "last_name": "Neafus",
      "permalink": "david-neafus-2",
      "image":
       {"available_sizes":
         [[[118,
            118],
           "assets/images/resized/0027/1865/271865v1-max-150x150.png"],
          [[118,
            118],
           "assets/images/resized/0027/1865/271865v1-max-250x250.png"],
          [[118,
            118],
           "assets/images/resized/0027/1865/271865v1-max-450x450.png"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$89.5M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.finsmes.com/2011/10/foundation-medicine-closes-33-5m-expanded-series-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Foundation Medicine Closes $33.5M Expanded Series A Financing",
    "raised_amount": 33500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 10,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Third Rock Ventures",
         "permalink": "third-rock-ventures-2",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0005/0700/50700v1-max-150x150.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-250x250.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kleiner Perkins Caufield \u0026 Byers",
         "permalink": "kleiner-perkins-caufield-byers",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Google Ventures",
         "permalink": "google-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/9829/39829v8-max-150x150.jpg"],
             [[250,
               116],
              "assets/images/resized/0003/9829/39829v8-max-250x250.jpg"],
             [[450,
               210],
              "assets/images/resized/0003/9829/39829v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.finsmes.com/2012/09/foundation-medicine-closes-42-5m-series-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Foundation Medicine Closes $42.5M Series B Funding",
    "raised_amount": 42500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 9,
    "funded_day": 20,
    "investments":
     [{"company":
        {"name": "Deerfield Management",
         "permalink": "deerfield-management",
         "image": null},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Casdin Capital",
         "permalink": "casdin-capital",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0021/8617/218617v1-max-150x150.jpg"],
             [[250,
               72],
              "assets/images/resized/0021/8617/218617v1-max-250x250.jpg"],
             [[450,
               129],
              "assets/images/resized/0021/8617/218617v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Redmile Group",
         "permalink": "redmile-group",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Roche Venture Fund",
         "permalink": "roche-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/6088/46088v1-max-150x150.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-250x250.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Third Rock Ventures",
         "permalink": "third-rock-ventures-2",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0005/0700/50700v1-max-150x150.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-250x250.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Google Ventures",
         "permalink": "google-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/9829/39829v8-max-150x150.jpg"],
             [[250,
               116],
              "assets/images/resized/0003/9829/39829v8-max-250x250.jpg"],
             [[450,
               210],
              "assets/images/resized/0003/9829/39829v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kleiner Perkins Caufield \u0026 Byers",
         "permalink": "kleiner-perkins-caufield-byers",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.foundationmedicine.com/pdf/news-releases/2013_01_08_FMI_Series_B_Ext_FINAL.pdf",
    "source_description": "Foundation Medicine Expands Series B Financing to $56 Million",
    "raised_amount": 13500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 1,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org": null,
       "person":
        {"first_name": "Bill",
         "last_name": "Gates",
         "permalink": "bill-gates",
         "image":
          {"available_sizes":
            [[[105,
               150],
              "assets/images/resized/0001/7609/17609v1-max-150x150.jpg"],
             [[175,
               250],
              "assets/images/resized/0001/7609/17609v1-max-250x250.jpg"],
             [[200,
               285],
              "assets/images/resized/0001/7609/17609v1-max-450x450.jpg"]],
           "attribution": ""}}},
      {"company": null,
       "financial_org": null,
       "person":
        {"first_name": "Yuri",
         "last_name": "Milner",
         "permalink": "yuri-milner",
         "image":
          {"available_sizes":
            [[[150,
               118],
              "assets/images/resized/0004/5568/45568v1-max-150x150.jpg"],
             [[250,
               197],
              "assets/images/resized/0004/5568/45568v1-max-250x250.jpg"],
             [[395,
               312],
              "assets/images/resized/0004/5568/45568v1-max-450x450.jpg"]],
           "attribution": ""}}},
      {"company": null,
       "financial_org": null,
       "person":
        {"first_name": "Evan",
         "last_name": "Jones",
         "permalink": "evan-jones-2",
         "image":
          {"available_sizes":
            [[[121,
               150],
              "assets/images/resized/0005/8985/58985v2-max-150x150.jpg"],
             [[202,
               250],
              "assets/images/resized/0005/8985/58985v2-max-250x250.jpg"],
             [[364,
               450],
              "assets/images/resized/0005/8985/58985v2-max-450x450.jpg"]],
           "attribution": ""}}}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "One Kendall Square",
    "address2": "Suite B3501",
    "zip_code": "02139 ",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "has appointed Maureen Cronin in the newly created role of senior vice president of research and product development",
    "stoned_year": 2010,
    "stoned_month": 11,
    "stoned_day": 12,
    "source_url": "http://www.masshightech.com/stories/2010/11/08/daily56-Foundation-Medicine-names-Cronin-as-new-SVP.html",
    "source_text": null,
    "source_description": "Foundation Medicine names Cronin as new SVP",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Foundation Medicine",
      "permalink": "foundation-medicine"}},
   {"description": "has inked a collaboration deal with Swiss drug giant Novartis AG to tailor Foundation\u00e2\u20ac\u2122s genome-based tests to Novartis\u00e2\u20ac\u2122 needs",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 4,
    "source_url": "http://www.masshightech.com/stories/2011/01/03/daily22-Foundation-Medicine-Novartis-team-up-on-cancer-diagnostics.html",
    "source_text": null,
    "source_description": "Foundation Medicine, Novartis team up on cancer diagnostics",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Foundation Medicine",
      "permalink": "foundation-medicine"}},
   {"description": "has named Gary Palmer as senior vice president, medical affairs and commercial development",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 19,
    "source_url": "http://www.masshightech.com/stories/2011/01/17/daily28-Foundation-Medicine-appoints-Palmer-to-new-VP-role.html",
    "source_text": null,
    "source_description": "Foundation Medicine appoints Palmer to new VP role",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Foundation Medicine",
      "permalink": "foundation-medicine"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}